New pill aims to break the cycle of recurring c. diff infections
NCT ID NCT07513285
First seen Apr 11, 2026 · Last updated Apr 30, 2026 · Updated 1 time
Summary
This study tests an oral drug called ibezapolstat in 20 adults who have had three or more C. difficile infections in the past year. The goal is to see if the drug can cure the current infection and prevent future ones by targeting the bacteria while protecting healthy gut bacteria. Participants will take the drug and be monitored for safety and recurrence.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLOSTRIDIUM DIFFICILE INFECTION RECURRENCE are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.